You are here

Industry Trends

Some experts still opposed to “right to try” treatments
Agency plans to respond after receipt of letter of concern
But some in industry disagree with the idea
Clinical trial of NIH-developed vaccine will evaluate effectiveness of the new agent
Six states will also participate in the litigation
Express Scripts to offer Praluent at roughly 60% off list price
Researchers found no association between clinical value and cost
Agency is not be seeking to participate as an active litigant
Researchers propose that pharmacists can help improve medication-related care and lower costs
Total global use of antibiotics increased nearly 40% in 15-year period
Company hopes added transparency will “rationalize” drug pricing
More than half of the drugs rose in price by more than 50% over five-year span
Advocacy groups, former FDA commissioners express concern